Technological Diversification and Innovation Performance

This paper analyzes the impact of technological diversity on innovation inputs and success using Swiss firm-level panel data. While we do not find any impact of diversity on R&D intensity, we confirm a positive impact of diversity on patent applications as suggested by the literature. However, since patent applications reflect an intermediate innovation input rather than output, we extend the analysis to the share of sales generated by new products. We find a significant negative effect of diversity on the sales share of new products. Hence, technologically more specialized firms have a lower propensity to patent and greater shares of new products. We find neither a direct nor indirect effect of diversity on the sales share generated by improved products. These results suggest that specialization pays-off through more drastic innovations that yield greater market success through a passing monopoly status.

[1]  U. Cantner,et al.  Technological Diversity and Future Product Diversity in the Drug Industry , 2009 .

[2]  Todd R. Zenger,et al.  Explaining Organizational Diseconomies of Scale in R&D: Agency Problems and the Allocation of Engineering Talent, Ideas, and Effort by Firm Size , 1994 .

[3]  Z. Griliches,et al.  Econometric Models for Count Data with an Application to the Patents-R&D Relationship , 1984 .

[4]  A. Kleinknecht,et al.  Innovative output, and a firm's propensity to patent.: an exploration of CIS micro data , 1999 .

[5]  M. Woerter.  Technology Diversification, Product Innovations, and Technology Transfer , 2009 .

[6]  Fr¬¥ed¬¥erique Sachwald,et al.  Co-operative R&D: why and with whom?: An integrated framework of analysis , 2003 .

[7]  Douglas J. Miller.  Technological diversity, related diversification, and firm performance , 2006 .

[8]  Daniel A. Levinthal,et al.  Exploration and Exploitation in Organizational Learning , 2007 .

[9]  Bart van Looy,et al.  Technological Diversification, Coherence and Performance of Firms , 2007 .

[10]  Z. Griliches.  Patent Statistics as Economic Indicators: a Survey , 1990 .

[11]  R. Nelson,et al.  On the Complex Economics of Patent Scope , 1990 .

[12]  K. Arrow.  Economic Welfare and the Allocation of Resources for Invention , 1962 .

[13]  A. Drejer.  Innovation and learning , 2003 .

[14]  Bengt Holmstrom,et al.  AGENCY COSTS AND INNOVATION , 1989 .

[15]  Kiminori Gemba,et al.  Diversification dynamics of the Japanese industry , 2001 .

[16]  Kwaku Atuahene-Gima,et al.  Cross-Functional Influence in New Product Development: An Exploratory Study of Marketing and R&D Perspectives , 2000 .

[17]  Hsien-che Lai,et al.  Technological Diversification, Complementary Assets, and Performance , 2008 .

[18]  María García‐Vega.  Does technological diversification promote innovation?: An empirical analysis for European firms , 2006 .

[19]  A. Cameron,et al.  Econometric models based on count data. Comparisons and applications of some estimators and tests , 1986 .

[20]  Competition, R&D and Innovation: Testing the Inverted-U in a Simultaneous System , 2013 .

[21]  F. Malerba,et al.  Knowledge-relatedness in firm technological diversification , 2003 .

[22]  Pier Paolo Saviotti,et al.  Coherence of the Knowledge Base and the Firm's Innovative Performance: Evidence from the U.S. Pharmaceutical Industry , 2005 .

[23]  M. Peneder.  Technological regimes and the variety of innovation behaviour: Creating integrated taxonomies of firms and sectors , 2010 .

[24]  Erwin Danneels.  The dynamics of product innovation and firm competences , 2002 .

[25]  T. Plotnikova.  Success in Pharmaceutical Research: The Changing Role of Scale and Scope Economies, Spillovers and Competition , 2010 .

[26]  Martin Woerter,et al.  Is there any Impact of University–Industry Knowledge Transfer on Innovation and Productivity? An Empirical Analysis Based on Swiss Firm Data , 2008 .

[27]  E. Mansfield,et al.  Organizational and Strategic Factors Associated with Probabilities of Success in Industrial R & D , 1975 .

[28]  Daniel A. Levinthal,et al.  Innovation and Learning: The Two Faces of R&D , 1989 .

[29]  Rebecca Henderson,et al.  Scale, Scope and Spillovers: The Determinants of Research Productivity in Ethical Drug Discovery , 2015 .

[30]  M. Carree,et al.  Cooperative R&D and Firm Performance , 2004 .

[31]  Amalia Yiannaka,et al.  Strategic patent breadth and entry deterrence with drastic product innovations , 2003 .

[32]  I. Cockburn,et al.  Scale, scope, and spillovers: the determinants of research productivity in drug discovery. , 1996, The Rand journal of economics.

[33]  F. J. Forcadell,et al.  Related diversification and R&D intensity dynamics , 2010 .

[34]  Z. Griliches,et al.  Industry Effects and Appropriability Measures in the Stock Markets Valuation of R&D and Patents , 1987 .

[35]  P. Danzon,et al.  Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances , 2003, Journal of health economics.

[36]  A. Gambardella,et al.  Does technological convergence imply convergence in markets? Evidence from the electronics industry , 1998 .

[37]  Daniel A. Levinthal,et al.  ABSORPTIVE CAPACITY: A NEW PERSPECTIVE ON LEARNING AND INNOVATION , 1990 .

[38]  Nicholas Argyres.  CAPABILITIES, TECHNOLOGICAL DIVERSIFICATION AND DIVISIONALIZATION , 1996 .

[39]  R. Nelson.  Recent Evolutionary Theorizing about Economic Change , 2005, Technology, Institutions, and Economic Growth.

[40]  Yongtae Park,et al.  How should firms carry out technological diversification to improve their performance? An analysis of patenting of Korean firms , 2009 .

[41]  Ashish Arora,et al.  A Breath of Fresh Air? Firm Type, Scale, Scope, and Selection Effects in Drug Development , 2009, Manag. Sci..